Science Explorer Interactive view Map
Company · Cambridge · United States

Cerulean Pharma (United States)

ROR OpenAlex
Research works
33
▼ 95% vs 2013–17
Citations
628
19.3 per fractional work
Top-10% rate
35.1%
record average 16.5%
Open access
25%
world 28%

Not ranked overall: Cerulean Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.29× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.89× its world share, 0 worksImmunology and Micro…Engineering: 1.15× its world share, 0 worksEngineeringMedicine: 1.16× its world share, 0 worksMedicineArts and Humanities: 5.96× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 5.34× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 6.61× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 6.6×. Every wedge is a field page.

Which keywords describe research at Cerulean Pharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Tumor Targeting, Nanoparticles, Immunotherapy, Chemotherapy, Cancer Therapy, Biomedical Applications, Drug Delivery and Nanocarriers.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Tumor Targeting8▲ 180×3 topics
  2. Nanoparticles7▲ 17×5 topics
  3. Immunotherapy6▲ 29×6 topics
  4. Chemotherapy6▲ 24×10 topics
  5. Cancer Therapy5▲ 22×4 topics
  6. Biomedical Applications4▲ 11×2 topics
  7. Drug Delivery4▲ 24×2 topics
  8. Nanocarriers3▲ 240×1 topic
  9. Surface Engineering3▲ 92×1 topic
  10. Reactive Oxygen Species3▲ 20×3 topics
  11. Photodynamic Therapy3▲ 60×2 topics
  12. Clinical Trials3▲ 14×5 topics
  13. Fluorescence Imaging3▲ 77×1 topic
  14. Photothermal Therapy3▲ 103×1 topic
  15. Targeted Therapy3▲ 37×4 topics
  16. Tumor Microenvironment3▲ 23×3 topics
  17. HIF-12▲ 104×1 topic
  18. Warburg Effect2▲ 104×1 topic
  19. DNA2▲ 213×1 topic
  20. Gene Therapy2▲ 25×2 topics
  21. Innovation2▲ 7.3×3 topics
  22. Topoisomerases2▲ 213×1 topic
  23. Metastatic Breast Cancer2▲ 88×2 topics
  24. Biomarkers2▲ 9.0×4 topics
  25. Quality of Life2▲ 4.2×3 topics
  26. Emerging Markets2▲ 104×2 topics
  27. Entrepreneurship2▲ 19×2 topics
  28. Prognostic Factors2▲ 12×3 topics
  29. Metastasis2▲ 14×3 topics
  30. Arginine Deprivation2▲ 105×1 topic
  31. Bacterial Therapy2▲ 105×1 topic
  32. Global Collaboration2▲ 113×1 topic
  33. Health Biotechnology2▲ 243×1 topic
  34. Chemotherapy-Induced Peripheral Neuropathy1▲ 85×1 topic
  35. Taxanes1▲ 85×1 topic
  36. Tumor Markers1▲ 61×2 topics
  37. Genomic Profiles1▲ 114×1 topic
  38. Small-Cell Lung Cancer1▲ 114×1 topic
  39. Analytics1▲ 57×1 topic
  40. Big Data1▲ 5.7×1 topic

Which research topics does Cerulean Pharma (United States) publish most on?

By volume in 2022–2025: Design Education and Practice, Crafts, Textile, and Design, Innovation and Socioeconomic Development and Pharmaceutical Economics and Policy.

Design Education and Practice: 0 fractional worksCrafts, Textile, and Design: 0 fractional worksInnovation and Socioeconomic Development: 0 fractional worksPharmaceutical Economics and Policy: 0 fractional worksBlood Pressure and Hypertension Studies: 0 fractional worksIon Transport and Channel Regulation: 0 fractional worksHormonal Regulation and Hypertension: 0 fractional works
Mechanical EngineeringMuseologyBusiness and International ManagementEconomics and Econometrics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Design Education and Practice Mechanical Engineering 0 works
  2. 2 Crafts, Textile, and Design Museology 0 works
  3. 3 Innovation and Socioeconomic Development Business and International Management 0 works
  4. 4 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  5. 5 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
  6. 6 Ion Transport and Channel Regulation Molecular Biology 0 works
  7. 7 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 0 works
  9. 9 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
  10. 10 Biosimilars and Bioanalytical Methods Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.0%not open75.0%

World: 28% of research is openly available.

with international co-authors20.4%domestic only79.6%

World: 19% is written across borders.

How has Cerulean Pharma (United States)'s research output changed?

Output in 2018–2022 was 95% lower than in 2013–2017.

199019952000200520102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.